Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity

The Journal of Clinical Endocrinology and Metabolism
A BereketT A Wilson

Abstract

Limited proteolysis of serum insulin-like growth factor (IGF) binding protein (IGFBP)-3 has been described in various conditions and may increase the bioavailability of IGFs. The physiological regulators of serum IGFBP-3 protease activity are unknown. To characterize the relationship between insulin and IGFBP-3 protease activity, we have examined serum IGFBP-3 proteolysis in children with untreated insulin-dependent diabetes mellitus (IDDM) and have followed the effect of insulin therapy on serum IGFBP-3 proteolysis at 1 day, 1 week, and 1 month after the initiation of insulin therapy. Ligand blot analysis of sera from untreated children with IDDM showed that intact IGFBP-3 was 50 +/- 9% of the age-matched control pool. After the initiation of insulin treatment, IGFBP-3 did not change significantly at 1 day after treatment but increased dramatically at 1 week (90 +/- 13%) and 1 month after treatment (102 +/- 13%). In contrast, when measured by immunoradiometric assay (which detects both intact and fragments of IGFBP-3), IGFBP-3 levels were 70% of the control pool before insulin therapy and did not increase significantly until 1 month after treatment. Immunoblot analysis demonstrated that intact IGFBP-3 doublet was diminished to...Continue Reading

Citations

Sep 16, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Victoria Schebek-FürstenbergBernd Kübler
Jul 20, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Svein I HellePer E Lønning
Jan 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Craig ParkinsonPeter J Trainer
Jun 2, 2005·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·S GustafssonP Bang
May 10, 2011·Metabolism: Clinical and Experimental·Frédéric De CeuninckAlain Ktorza
Oct 28, 2006·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Claus Højbjerg GravholtAllan Flyvbjerg
Feb 22, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·S KucG H A Visser
Sep 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Jan Frystyk
Jul 12, 2005·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·D R ClemmonsG Allan
Oct 21, 1999·Molecular Genetics and Metabolism·L A WetterauP Cohen
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Helene NørrelundAllan Flyvbjerg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.